Is parenteral methotrexate worth trying?
作者信息
Osman A, Mulherin D
出版信息
Ann Rheum Dis. 2001 Apr;60(4):432. doi: 10.1136/ard.60.4.432.
Abstract
摘要
相似文献
1
Is parenteral methotrexate worth trying?肠胃外注射甲氨蝶呤值得一试吗？
Ann Rheum Dis. 2001 Apr;60(4):432. doi: 10.1136/ard.60.4.432.
2
Self-injection of gold and methotrexate.
J Rheumatol. 2001 Jan;28(1):212.
3
Parenteral methotrexate for the treatment of rheumatoid arthritis.用于治疗类风湿关节炎的肠胃外甲氨蝶呤
Bull Hosp Jt Dis (2013). 2013;71 Suppl 1:46-8.
4
Intramuscular methotrexate in inflammatory rheumatic disease.
Ann Rheum Dis. 2001 Dec;60(12):1156. doi: 10.1136/ard.60.12.1156.
5
Comment on: Use of parenteral methotrexate significantly reduces the need for biological therapy.
Rheumatology (Oxford). 2008 Sep;47(9):1438; author reply 1438. doi: 10.1093/rheumatology/ken250. Epub 2008 Jul 10.
6
Relapse of rheumatoid arthritis after substitution of oral for parenteral administration of methotrexate.甲氨蝶呤由肠外给药改为口服给药后类风湿关节炎复发。
Ann Rheum Dis. 2002 Aug;61(8):756-7. doi: 10.1136/ard.61.8.756.
7
Subcutaneous methotrexate is well tolerated and superior to oral methotrexate in the treatment of rheumatoid arthritis.皮下注射甲氨蝶呤耐受性良好，在类风湿关节炎的治疗中优于口服甲氨蝶呤。
Int J Rheum Dis. 2010 Oct;13(4):e83-4. doi: 10.1111/j.1756-185X.2010.01482.x.
8
Better efficacy of methotrexate given by intramuscular injection than orally in patients with rheumatoid arthritis.对于类风湿关节炎患者，肌内注射甲氨蝶呤的疗效优于口服给药。
Ann Rheum Dis. 2004 Oct;63(10):1232-4. doi: 10.1136/ard.2003.011593.
9
Oral Methotrexate in split dose weekly versus oral or parenteral Methotrexate once weekly in Rheumatoid Arthritis: a short-term study.口服甲氨蝶呤每周分剂量给药与口服或胃肠外甲氨蝶呤每周一次给药治疗类风湿关节炎的短期研究
Int J Rheum Dis. 2018 May;21(5):1010-1017. doi: 10.1111/1756-185X.12910. Epub 2016 Jul 26.
10
[Methotrexate: advantages of subcutaneous administration].
Z Rheumatol. 2008 Jul;67(4):332-3. doi: 10.1007/s00393-008-0295-4.
引用本文的文献
1
Should All Patients Trial Subcutaneous Methotrexate Prior to Commencing Biologic Therapy? A Real World Study.所有患者在开始生物治疗前都应试用皮下注射甲氨蝶呤吗？一项真实世界研究。
Mediterr J Rheumatol. 2023 Sep 4;35(1):115-122. doi: 10.31138/mjr.140423.sat. eCollection 2024 Mar.
2
Benefits of Switch from Oral to Subcutaneous Route on Adherence to Methotrexate in Patients with Rheumatoid Arthritis in Real Life Setting.在现实生活环境中，类风湿关节炎患者从口服甲氨蝶呤转换为皮下注射给药途径对治疗依从性的益处。
Patient Prefer Adherence. 2021 Apr 14;15:751-760. doi: 10.2147/PPA.S301010. eCollection 2021.
3
Assessing usability, label comprehension, pen robustness and pharmacokinetics of a self-administered prefilled autoinjector pen of methotrexate in patients with rheumatoid arthritis.评估甲氨蝶呤预填充自动注射笔在类风湿关节炎患者中的可用性、标签理解度、笔的耐用性及药代动力学。
SAGE Open Med. 2014 Dec 22;2:2050312114564241. doi: 10.1177/2050312114564241. eCollection 2014.
4
Better efficacy of methotrexate given by intramuscular injection than orally in patients with rheumatoid arthritis.对于类风湿关节炎患者，肌内注射甲氨蝶呤的疗效优于口服给药。
Ann Rheum Dis. 2004 Oct;63(10):1232-4. doi: 10.1136/ard.2003.011593.
5
Comparison of the efficacy of the tumour necrosis factor alpha blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis.肿瘤坏死因子α阻断剂阿达木单抗、依那西普和英夫利昔单抗在甲氨蝶呤基础上加用治疗活动性类风湿关节炎患者时的疗效比较。
Ann Rheum Dis. 2003 Nov;62 Suppl 2(Suppl 2):ii13-6. doi: 10.1136/ard.62.suppl_2.ii13.
Zotero 插件